Halyard Health, Inc. operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management. Its products include post-operative pain management solutions, minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. This segment sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and other brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. Halyard Health, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:HYH
Previous Symbol
CUSIPN/A
Phone678-425-9273
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees13,000
Outstanding SharesN/A
Market Cap$0.00
OptionableOptionable
Halyard Health (NYSE:HYH) Frequently Asked Questions
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health (NYSE:HYH) released its quarterly earnings data on Wednesday, November, 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to analysts' expectations of $394.54 million. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.48 EPS. View Halyard Health's Earnings History.
What price target have analysts set for HYH?
4 Wall Street analysts have issued 12 month price targets for Halyard Health's stock. Their predictions range from $50.00 to $67.00. On average, they anticipate Halyard Health's share price to reach $59.25 in the next year. This suggests a possible upside of 3.5% from the stock's current price. View Analyst Price Targets for Halyard Health.
What is the consensus analysts' recommendation for Halyard Health?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halyard Health in the last year. There are currently 1 sell rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Halyard Health.
Has Halyard Health been receiving favorable news coverage?
News headlines about HYH stock have been trending negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Halyard Health earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.
Who are some of Halyard Health's key competitors?
Some companies that are related to Halyard Health include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Smith & Nephew (SNN), Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Sientra (SIEN) and RTI Surgical (RTIX).
Who are Halyard Health's key executives?
Halyard Health's management team includes the folowing people:
- Mr. Steven E. Voskuil, Sr. VP & CFO (Age 50)
- Mr. John W. Wesley, Sr. VP & Gen. Counsel (Age 59)
- Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 50)
- Mr. Joseph F. Woody, CEO & Director (Age 52)
- Mr. Renato Negro, VP, Controller & Chief Accounting Officer
Who are Halyard Health's major shareholders?
Which major investors are buying Halyard Health stock?
How do I buy shares of Halyard Health?
Shares of HYH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Halyard Health's stock price today?
One share of HYH stock can currently be purchased for approximately $57.25.
What is Halyard Health's official website?
How can I contact Halyard Health?
Halyard Health's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier can be reached via phone at 678-425-9273 or via email at [email protected]
MarketBeat Community Rating for Halyard Health (NYSE HYH)
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe HYH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYH will underperform the S&P 500 over the long term. You may vote once every thirty days.
